6505--Lab supplies - Radiopharm - Amyvid
ID: 36C24425Q0392Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF244-NETWORK CONTRACT OFFICE 4 (36C244)PITTSBURGH, PA, 15215, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/8a10372e67f84e1e9f96ee153ae7c02b/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for a five-year indefinite delivery indefinite quantity (IDIQ) contract to supply Amyvid injectables for Positron Emission Tomography (PET) imaging at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, Pennsylvania. The contract will require an estimated thirty-six doses of Amyvid per year, which are critical for diagnosing Alzheimer's disease in veterans. Proposals are due by 3:00 PM EST on March 6, 2025, with questions accepted until March 4, 2025, and the total contract value is capped at $1,000,000. Interested vendors must comply with federal regulations and safety guidelines, and they can contact Contracting Officer Victoria Droz at Victoria.Droz@va.gov or 814-515-4454 for further information.

    Point(s) of Contact
    Contracting OfficerVictoria Droz
    (814) 515-4454
    Victoria.Droz@va.gov
    Files
    Title
    Posted
    36C24425Q0392_1.docx
    The document serves as a Presolicitation Notice from the Department of Veterans Affairs (VA) regarding the procurement of Amyvid injections for the Philadelphia Veterans Affairs Medical Center (VAMC). The solicitation, identified by number 36C24425Q0392, invites offers on an unrestricted competitive basis with a response deadline set for February 27, 2025, at 12:00 PM Eastern Time. The procurement falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing and is situated in Pittsburgh, PA. The notice emphasizes that it does not obligate the government to award a contract or incur costs related to proposal preparation. Potential vendors are encouraged to regularly check the Contract Opportunities website for updates and amendments to the solicitation, which will be exclusively available there. All interested parties must be registered with the System for Award Management (SAM). The Contracting Officer, Victoria Droz, is the designated point of contact, and inquiries must be submitted via email, as phone inquiries are not permitted. The document outlines the importance of compliance with procurement guidelines and stresses that no additional information will be provided until the formal solicitation is issued.
    36C24425Q0392 RFQ.pdf
    The Department of Veterans Affairs is soliciting proposals for a five-year indefinite delivery indefinite quantity (IDIQ) contract to supply Amyvid injectables for Positron Emission Tomography (PET) imaging at the Corporal Michael J. Crescenz VA Medical Center (CMCVAMC). The contract will require an estimated thirty-six doses of Amyvid per year to aid in diagnosing Alzheimer's disease. Proposals are due by 3:00 PM EST on March 6, 2025, with questions accepted until March 4, 2025. Payments will be made electronically, and the government has set minimum order limits at $1,000 and maximums at $500,000 for individual items, with total contract limits reaching $1,000,000. Participants must agree to comply with applicable federal regulations and safety guidelines throughout the contract period, which begins on March 14, 2025, and concludes on March 13, 2030. The solicitation emphasizes the necessity for new, FDA-approved products and mandates adherence to standards for safety, labor regulations, and subcontracting practices, reflecting the government's commitment to obtaining quality medical supplies for veterans’ healthcare services.
    Lifecycle
    Title
    Type
    6505--Lab supplies - Radiopharm - Amyvid
    Currently viewing
    Solicitation
    6505--Lab supplies - Radiopharm - Amyvid
    Presolicitation
    Similar Opportunities
    6525--Nuclear Medicine NEURACEQ F-18 FLORBETABEN PET DEP
    Buyer not available
    The Department of Veterans Affairs is seeking small business vendors to provide F-18 Florbetaben PET doses for the Lexington VA Medical Center, as outlined in the combined synopsis and solicitation (RFQ 36C24925Q0157). The procurement involves a five-year contract for the delivery of specified quantities of radiopharmaceuticals, with orders required to be placed 24 hours prior to patient studies and delivered 15-30 minutes before calibration time. This initiative is crucial for ensuring timely access to essential medical imaging supplies, thereby enhancing the quality of healthcare services provided to veterans. Interested vendors must submit their quotes by March 6, 2025, and can direct inquiries to Contract Specialist Ayslin Kennett at Ayslin.Kennett@va.gov.
    6505--Radiopharmaceuticals For The Portland VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceuticals for the Portland VA Medical Center. This opportunity, identified by solicitation number 36C26025Q0237, aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply essential nuclear medicine supplies, ensuring 24/7 availability and prompt delivery for patient care. The procurement is particularly significant as it supports the medical needs of veterans while promoting participation from Service-Disabled Veteran-Owned Small Businesses (SDVOSB). Interested vendors must submit their proposals by March 28, 2025, at 13:00 Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6505--Notice of Intent to Sole Source F18 Piflufolastat (PYLARIFY) Doses for PET/CT for Overton Brooks VA Medical Center, Shreveport, LA
    Buyer not available
    The Department of Veterans Affairs intends to award a sole-source contract to Progenics Pharmaceuticals, Inc. for the provision of 200 doses of F-18 Pifluflostat (PYLARIFY) for the Overton Brooks VA Medical Center in Shreveport, LA. The contractor must be licensed and experienced in supplying radiopharmaceuticals, ensuring compliance with regulatory standards set by the Nuclear Regulatory Commission and the FDA, and providing daily or as-needed deliveries to the facility's Nuclear Medicine department. This specialized radiopharmaceutical is crucial for PET imaging in prostate cancer patients, reflecting the government's commitment to high healthcare standards and patient safety. Interested vendors must submit their capability statements by March 3, 2025, and all inquiries should be directed to the contracting officer, Ross Futch, at ross.futch@va.gov or by phone at 713-770-2830.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Mycophenolate Mofetil capsules and tablets under Solicitation Number 36E79725R0010, aimed at establishing national pricing for these pharmaceutical products. The contract is intended to support various government health care facilities, including those under the Department of Defense and Indian Health Service, ensuring compliance with FDA standards and the Drug Supply Chain Security Act. Offerors are required to submit pricing for both the base year and four option years, with a deadline for submissions extended to March 4, 2025, at 2:30 PM CST, and must acknowledge receipt of this amendment to avoid rejection of their offers. Interested parties can contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further information.
    6505--Radiopharmaceutical Isotopes (Cardiology)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals from qualified small businesses for the provision of radiopharmaceutical isotopes specifically for use in nuclear cardiology procedures at the William S. Middleton Memorial Veterans Hospital in Madison, WI. The procurement aims to secure isotopes such as 99mTc-Tetrofosmin and 131I-Sodium Iodide, which are critical for diagnostic testing and quality assurance, with a contract period extending from April 1, 2025, to March 31, 2030, and options for renewal. Vendors must ensure compliance with safety regulations, quality control, and confidentiality in handling patient data, while providing robust ordering systems and next-day service capabilities. Interested parties should contact Contracting Officer Stacy Massey at Stacy.Massey@va.gov or 414-844-8400 for further details and to submit their quotes by the specified deadlines.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bevacizumab injections, a critical pharmaceutical product used in various healthcare settings for veterans. Vendors are required to meet specific criteria, including providing unique National Drug Codes (NDC) and adhering to the Drug Supply Chain Security Act regulations, as the contract aims to ensure a reliable supply of this medication across government health care facilities. The selected contractor will be responsible for multiple line items of different Bevacizumab formulations, maintaining compliance with FDA manufacturing practices, and submitting quarterly sales reports, including cost recovery fees. Interested vendors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details, with submissions due by the specified deadlines outlined in the solicitation document.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and related pharmaceutical products under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for the Department of Veterans Affairs and the Department of Defense, requiring offerors to submit competitive pricing for a base year plus four option years, including a 0.5% Cost Recovery Fee. Compliance with the Drug Supply Chain Security Act (DSCSA), adherence to current good manufacturing practices (cGMP), and provision of unique National Drug Codes (NDC) for the offered products are critical requirements. Interested parties should direct inquiries to Contract Specialist Billy Fong at Billy.Fong@va.gov, with proposals due by the specified deadline outlined in the solicitation document.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the provision of radiopharmaceuticals to the Naval Medical Center Portsmouth, with a contract period extending from April 1, 2025, to March 31, 2030. The procurement encompasses a range of medical isotopes and imaging agents, including Tc-99m Medronate, I-123 NaI, and F-18 FDG, which are critical for various diagnostic and therapeutic applications in cancer treatment and medical imaging. This initiative underscores the government's commitment to ensuring the availability of essential medical resources to support public health initiatives, with a focus on compliance with safety regulations and quality standards. Interested vendors must submit their proposals by March 11, 2025, and direct any inquiries to Carol Uebelacker at carol.e.uebelacker.civ@health.mil or by phone at 210-952-8111.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.